Rare diseases
Investigational molecules
Locations
Ronda General Mitre 151, 08022 Barcelona, Spain
Research activity is centred on moderate-to-severe atopic dermatitis, with additional interest in nummular dermatitis and broader eczema management in adults and adolescents. The sponsor’s portfolio reflects sustained attention to disease control, symptom relief, and longer-term treatment use in chronic inflammatory skin disease.
These studies focus on persistent cutaneous inflammation and the clinical burden of recurrent pruritus, erythema, and skin barrier dysfunction.
Almirall S.A. runs clinical trials in conditions such as Dermatitis atopic, Hidradenitis, Actinic keratosis, Alopecia areata, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
BulgariaA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
BulgariaA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
BulgariaA Study of LAD191 Compared to Placebo and Adalimumab in Adults with Moderate-to-Severe Hidradenitis Suppurativa
FranceEfficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
DenmarkA Phase 2 Study of LAD603 in Adults with Systemic Lupus Erythematosus and Active Skin Rash
BulgariaStudy on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanySafety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby
SpainStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
AustriaStudy on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp
FranceStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Tirbanibulin Ointment for Adults with Actinic Keratosis on the Face or Scalp
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
